Literature DB >> 25003832

Transient ileus associated with the use of mydriatics after screening for retinopathy of prematurity in a very low birth weight infant.

Halil Degirmencioglu, Mehmet Yekta Oncel, Erhan Calisici, Birgul Say, Nurdan Uras, Ugur Dilmen.   

Abstract

Very low birth weight (VLBW) infants have ophthalmologic examinations for retinopathy of prematurity (ROP) prior to discharge, with appropriate follow-up and intervention where appropriate. Eye drops such as cylopentolate, tropicamide, and phenylephrine are used at different concentrations to provide proper pupil dilation for screening ROP. Topical instillation of eye drops may cause mild or severe ocular or systemic adverse effects. Early recognition of systemic toxicity after eye drop instillation is important. The authors present a case of a VLBW infant who developed significant abdominal symptoms (mimicking ileus) that were significant enough to discontinue oral feeding after ocular instillation of 0.5% tropicamide and 2.5% phenylephrine eye drops for routine examination of ROP. After structural and functional gastrointestinal disorders and sepsis were excluded, symptoms resolved completely after discontinuation of the drug. This report is thought to be the first in the medical literature to address 5% tropicamide and 2.5% phenylephrine eye drops, and the combination that may lead to serious complication after ROP examinations. Copyright 2014, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25003832     DOI: 10.3928/01913913-20140701-02

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  6 in total

1.  Safety of Retinopathy of Prematurity Examination and Imaging in Premature Infants.

Authors:  Kelly C Wade; Maxwell Pistilli; Agnieshka Baumritter; Karen Karp; Alice Gong; Alex R Kemper; Gui-Shuang Ying; Graham Quinn
Journal:  J Pediatr       Date:  2015-08-20       Impact factor: 4.406

2.  Systemic changes and adverse effects induced by retinopathy of prematurity screening.

Authors:  Jing-Bo Jiang; Zhi-Wei Zhang; Jia-Wen Zhang; Yan-Li Wang; Chuan Nie; Xian-Qiong Luo
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

3.  Do extremely preterm infants need retinopathy of prematurity screening earlier than 31 weeks postmenstrual age?

Authors:  Amy J Sloane; Elizabeth A O'Donnell; Amy B Mackley; Julia E Reid; Jay S Greenspan; David A Paul; Zubair H Aghai
Journal:  J Perinatol       Date:  2020-05-06       Impact factor: 2.521

4.  Differential effects of the retinopathy of prematurity exam on the physiology of premature infants.

Authors:  John B C Tan; Jennifer Dunbar; Andrew Hopper; Christopher G Wilson; Danilyn M Angeles
Journal:  J Perinatol       Date:  2019-02-12       Impact factor: 2.521

5.  Estimation of Gestational Age via Image Analysis of Anterior Lens Capsule Vascularity in Preterm Infants: A Pilot Study.

Authors:  Monalisa Patel; Dibyendu Mukherjee; Sina Farsiu; Breda Munoz; Arlin B Blood; Christopher G Wilson; Jennifer B Griffin
Journal:  Front Pediatr       Date:  2019-02-20       Impact factor: 3.418

6.  Systematic review of mydriatics used for screening of retinopathy in premature infants.

Authors:  Lisa Jean Kremer; David M Reith; Natalie Medlicott; Roland Broadbent
Journal:  BMJ Paediatr Open       Date:  2019-05-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.